News

Is the cost of research aimed at curing HIV worth it, when HIV can be effectively managed and prevented by existing drugs?
The FDA has approved a breakthrough preventative treatment for HIV that could change the course of the AIDS epidemic. But ...
A recent study analyzes the extent to which HIV tests are conducted following the diagnosis of an HIV indicator condition (IC ...
The COVID-19 pandemic paused many HIV prevention efforts, which helped fuel last year's rise in new infections. President ...
Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A ...
There are many diseases that mosquitoes can transmit, but HIV isn't one of them. Here's why, and what viruses you do need to watch out for depending on where you live.
Uganda's fight against HIV has shown measurable progress, with more people now accessing testing, treatment, and achieving viral suppression than ever before, according to new 2024 data from the ...
Writing in the latest edition of the journal, the editors argue that the Trump administration’s recent dismantling of public ...
UNAIDS statistics indicate that adolescent girls and young women (AGYW) aged 15-24 years continue to face a significant risk of HIV acquisition.
National and sub-national HIV/AIDS epidemiology, socioeconomic influences, and risk factors in Iran from 1990 to 2021, global burden of disease 2021 study Seyed Aria Nejadghaderi Mohammad-Mahdi Bastan ...
To My Friends in the LGBT Community: Wow, what an incredible journey I’ve been on over the past three years. I’ve learned so much about myself, HIV, and stigma. It all started out when I was ...
Gilead Sciences has achieved success with its HIV treatment drugs, including tenofovir disoproxil fumarate, but faces criticism for pricing and access issues. Learn about the controversy and ...